CA2584984A1 - Methods for assembly of high fidelity synthetic polynucleotides - Google Patents
Methods for assembly of high fidelity synthetic polynucleotides Download PDFInfo
- Publication number
- CA2584984A1 CA2584984A1 CA002584984A CA2584984A CA2584984A1 CA 2584984 A1 CA2584984 A1 CA 2584984A1 CA 002584984 A CA002584984 A CA 002584984A CA 2584984 A CA2584984 A CA 2584984A CA 2584984 A1 CA2584984 A1 CA 2584984A1
- Authority
- CA
- Canada
- Prior art keywords
- oligonucleotides
- pool
- construct
- construction
- construction oligonucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 516
- 102000040430 polynucleotide Human genes 0.000 title claims description 328
- 108091033319 polynucleotide Proteins 0.000 title claims description 328
- 239000002157 polynucleotide Substances 0.000 title claims description 328
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 760
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 622
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 287
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 247
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 247
- 108020004414 DNA Proteins 0.000 claims abstract description 172
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 89
- 230000003321 amplification Effects 0.000 claims abstract description 88
- 230000009467 reduction Effects 0.000 claims abstract description 46
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 39
- -1 that is Proteins 0.000 claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 claims abstract description 15
- 229920000642 polymer Polymers 0.000 claims abstract description 5
- 238000010276 construction Methods 0.000 claims description 391
- 238000009396 hybridization Methods 0.000 claims description 155
- 230000000295 complement effect Effects 0.000 claims description 115
- 239000000203 mixture Substances 0.000 claims description 95
- 108090000623 proteins and genes Proteins 0.000 claims description 85
- 230000008569 process Effects 0.000 claims description 79
- 238000003776 cleavage reaction Methods 0.000 claims description 72
- 239000007787 solid Substances 0.000 claims description 72
- 230000007017 scission Effects 0.000 claims description 71
- 108091008146 restriction endonucleases Proteins 0.000 claims description 62
- 230000015572 biosynthetic process Effects 0.000 claims description 60
- 101710163270 Nuclease Proteins 0.000 claims description 56
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 56
- 239000003795 chemical substances by application Substances 0.000 claims description 55
- 229920001184 polypeptide Polymers 0.000 claims description 53
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 53
- 108020004705 Codon Proteins 0.000 claims description 51
- 238000002844 melting Methods 0.000 claims description 51
- 230000008018 melting Effects 0.000 claims description 51
- 239000012634 fragment Substances 0.000 claims description 49
- 102000004169 proteins and genes Human genes 0.000 claims description 49
- 238000006243 chemical reaction Methods 0.000 claims description 43
- 239000002773 nucleotide Substances 0.000 claims description 38
- 125000003729 nucleotide group Chemical group 0.000 claims description 38
- 101710099953 DNA mismatch repair protein msh3 Proteins 0.000 claims description 36
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 34
- 238000001914 filtration Methods 0.000 claims description 34
- 102000004190 Enzymes Human genes 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 30
- 230000014509 gene expression Effects 0.000 claims description 30
- 230000000692 anti-sense effect Effects 0.000 claims description 29
- 239000011541 reaction mixture Substances 0.000 claims description 28
- 238000011946 reduction process Methods 0.000 claims description 28
- 102000004533 Endonucleases Human genes 0.000 claims description 27
- 108010042407 Endonucleases Proteins 0.000 claims description 27
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 26
- 238000012937 correction Methods 0.000 claims description 26
- 238000000926 separation method Methods 0.000 claims description 25
- 238000011282 treatment Methods 0.000 claims description 23
- 230000002194 synthesizing effect Effects 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 21
- 238000004925 denaturation Methods 0.000 claims description 19
- 230000036425 denaturation Effects 0.000 claims description 19
- 101100185881 Clostridium tetani (strain Massachusetts / E88) mutS2 gene Proteins 0.000 claims description 18
- 108060002716 Exonuclease Proteins 0.000 claims description 18
- 102000013165 exonuclease Human genes 0.000 claims description 18
- 101150117187 glmS gene Proteins 0.000 claims description 18
- 230000033607 mismatch repair Effects 0.000 claims description 18
- 101150013854 mutS gene Proteins 0.000 claims description 18
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 claims description 17
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 claims description 17
- 239000011324 bead Substances 0.000 claims description 17
- 229960002685 biotin Drugs 0.000 claims description 17
- 235000020958 biotin Nutrition 0.000 claims description 17
- 239000011616 biotin Substances 0.000 claims description 17
- 230000002255 enzymatic effect Effects 0.000 claims description 17
- 239000013598 vector Substances 0.000 claims description 16
- 230000002829 reductive effect Effects 0.000 claims description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims description 14
- 238000002955 isolation Methods 0.000 claims description 14
- 238000006386 neutralization reaction Methods 0.000 claims description 14
- 238000004153 renaturation Methods 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 238000012986 modification Methods 0.000 claims description 12
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 claims description 11
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 claims description 11
- 238000001514 detection method Methods 0.000 claims description 11
- 230000004048 modification Effects 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 11
- 108700010070 Codon Usage Proteins 0.000 claims description 10
- 108020001738 DNA Glycosylase Proteins 0.000 claims description 10
- 108010063362 DNA-(Apurinic or Apyrimidinic Site) Lyase Proteins 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 102000028381 DNA glycosylase Human genes 0.000 claims description 9
- 102000010719 DNA-(Apurinic or Apyrimidinic Site) Lyase Human genes 0.000 claims description 9
- 238000007792 addition Methods 0.000 claims description 9
- 230000002441 reversible effect Effects 0.000 claims description 9
- 229910015837 MSH2 Inorganic materials 0.000 claims description 8
- 108091030071 RNAI Proteins 0.000 claims description 8
- 108020001507 fusion proteins Proteins 0.000 claims description 8
- 102000037865 fusion proteins Human genes 0.000 claims description 8
- 238000001502 gel electrophoresis Methods 0.000 claims description 8
- 230000009368 gene silencing by RNA Effects 0.000 claims description 8
- 108091035707 Consensus sequence Proteins 0.000 claims description 7
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 claims description 7
- 108091064358 Holliday junction Proteins 0.000 claims description 7
- 102000039011 Holliday junction Human genes 0.000 claims description 7
- 238000004440 column chromatography Methods 0.000 claims description 7
- 239000000356 contaminant Substances 0.000 claims description 7
- 101150049514 mutL gene Proteins 0.000 claims description 7
- 101150029137 mutY gene Proteins 0.000 claims description 7
- 102100029075 Exonuclease 1 Human genes 0.000 claims description 6
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 claims description 6
- 102000003960 Ligases Human genes 0.000 claims description 6
- 108090000364 Ligases Proteins 0.000 claims description 6
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 claims description 6
- 108010086093 Mung Bean Nuclease Proteins 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 6
- 108091023037 Aptamer Proteins 0.000 claims description 5
- 102100037700 DNA mismatch repair protein Msh3 Human genes 0.000 claims description 5
- 102100021147 DNA mismatch repair protein Msh6 Human genes 0.000 claims description 5
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 5
- 101001027762 Homo sapiens DNA mismatch repair protein Msh3 Proteins 0.000 claims description 5
- 101000968658 Homo sapiens DNA mismatch repair protein Msh6 Proteins 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 5
- 101150052580 dam gene Proteins 0.000 claims description 5
- 239000002158 endotoxin Substances 0.000 claims description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 5
- 229920006008 lipopolysaccharide Polymers 0.000 claims description 5
- 101150031310 mutH gene Proteins 0.000 claims description 5
- 238000003499 nucleic acid array Methods 0.000 claims description 5
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 4
- 101150116644 FPG1 gene Proteins 0.000 claims description 4
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 claims description 4
- 101100067137 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) fpg gene Proteins 0.000 claims description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 4
- 239000013043 chemical agent Substances 0.000 claims description 4
- 101150036185 dnaQ gene Proteins 0.000 claims description 4
- 230000011987 methylation Effects 0.000 claims description 4
- 238000007069 methylation reaction Methods 0.000 claims description 4
- 101150104294 mutM gene Proteins 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 108020005065 3' Flanking Region Proteins 0.000 claims description 3
- 108020005029 5' Flanking Region Proteins 0.000 claims description 3
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 230000017858 demethylation Effects 0.000 claims description 3
- 238000010520 demethylation reaction Methods 0.000 claims description 3
- 101150008507 dnaE gene Proteins 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000002510 pyrogen Substances 0.000 claims description 3
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 2
- 101000877447 Enterobacteria phage T4 Endonuclease V Proteins 0.000 claims description 2
- 108010046914 Exodeoxyribonuclease V Proteins 0.000 claims description 2
- 102100037091 Exonuclease V Human genes 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 102000055027 Protein Methyltransferases Human genes 0.000 claims description 2
- 108700040121 Protein Methyltransferases Proteins 0.000 claims description 2
- 101150005418 RAD27 gene Proteins 0.000 claims description 2
- 101100220612 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chk1 gene Proteins 0.000 claims description 2
- 101100443856 Streptococcus pyogenes serotype M18 (strain MGAS8232) polC gene Proteins 0.000 claims description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 101150035285 dnaE1 gene Proteins 0.000 claims description 2
- 101150003155 dnaG gene Proteins 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 229940104230 thymidine Drugs 0.000 claims description 2
- 229920002477 rna polymer Polymers 0.000 claims 6
- 238000002407 reforming Methods 0.000 claims 3
- 238000004132 cross linking Methods 0.000 claims 2
- 230000000717 retained effect Effects 0.000 claims 2
- 238000003860 storage Methods 0.000 claims 2
- 239000004971 Cross linker Substances 0.000 claims 1
- 101000889812 Enterobacteria phage T4 Endonuclease Proteins 0.000 claims 1
- 108090000652 Flap endonucleases Proteins 0.000 claims 1
- 102000004150 Flap endonucleases Human genes 0.000 claims 1
- 238000002523 gelfiltration Methods 0.000 claims 1
- 101150060505 polC gene Proteins 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 238000013461 design Methods 0.000 abstract description 18
- 238000003491 array Methods 0.000 abstract description 13
- 238000005457 optimization Methods 0.000 abstract description 11
- 239000013615 primer Substances 0.000 description 137
- 239000000047 product Substances 0.000 description 101
- 210000004027 cell Anatomy 0.000 description 52
- 108091028043 Nucleic acid sequence Proteins 0.000 description 50
- 230000027455 binding Effects 0.000 description 50
- 238000009739 binding Methods 0.000 description 50
- 235000018102 proteins Nutrition 0.000 description 40
- 241000282414 Homo sapiens Species 0.000 description 33
- 108091027967 Small hairpin RNA Proteins 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 30
- 150000001413 amino acids Chemical class 0.000 description 29
- 238000003752 polymerase chain reaction Methods 0.000 description 23
- 125000005647 linker group Chemical group 0.000 description 21
- 102000053602 DNA Human genes 0.000 description 20
- 239000011230 binding agent Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 238000003780 insertion Methods 0.000 description 16
- 230000037431 insertion Effects 0.000 description 16
- 239000003550 marker Substances 0.000 description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 15
- 241000700605 Viruses Species 0.000 description 15
- 230000006870 function Effects 0.000 description 15
- 238000012217 deletion Methods 0.000 description 14
- 230000037430 deletion Effects 0.000 description 14
- 238000000137 annealing Methods 0.000 description 12
- 230000002596 correlated effect Effects 0.000 description 12
- 241000219195 Arabidopsis thaliana Species 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 11
- 239000013604 expression vector Substances 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 241000255601 Drosophila melanogaster Species 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 238000013459 approach Methods 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000002493 microarray Methods 0.000 description 10
- 238000010187 selection method Methods 0.000 description 10
- 241000699660 Mus musculus Species 0.000 description 9
- 238000001415 gene therapy Methods 0.000 description 9
- 238000005304 joining Methods 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 8
- 102000010645 MutS Proteins Human genes 0.000 description 8
- 108010038272 MutS Proteins Proteins 0.000 description 8
- 238000000429 assembly Methods 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- 150000008300 phosphoramidites Chemical class 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 229940035893 uracil Drugs 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 108020004566 Transfer RNA Proteins 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000013603 viral vector Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000033616 DNA repair Effects 0.000 description 6
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 6
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 230000002238 attenuated effect Effects 0.000 description 6
- 238000010494 dissociation reaction Methods 0.000 description 6
- 230000005593 dissociations Effects 0.000 description 6
- 238000002515 oligonucleotide synthesis Methods 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 241001529453 unidentified herpesvirus Species 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 208000035657 Abasia Diseases 0.000 description 5
- 102000016077 MutL Proteins Human genes 0.000 description 5
- 108010010712 MutL Proteins Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 238000004590 computer program Methods 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 5
- FSASIHFSFGAIJM-UHFFFAOYSA-N 3-methyladenine Chemical compound CN1C=NC(N)=C2N=CN=C12 FSASIHFSFGAIJM-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 4
- 102000011724 DNA Repair Enzymes Human genes 0.000 description 4
- 108010076525 DNA Repair Enzymes Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 102100026406 G/T mismatch-specific thymine DNA glycosylase Human genes 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 229910052775 Thulium Inorganic materials 0.000 description 4
- 108010035344 Thymine DNA Glycosylase Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 238000007857 nested PCR Methods 0.000 description 4
- 239000002777 nucleoside Substances 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 235000004252 protein component Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 238000010361 transduction Methods 0.000 description 4
- 230000026683 transduction Effects 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- CLGFIVUFZRGQRP-UHFFFAOYSA-N 7,8-dihydro-8-oxoguanine Chemical compound O=C1NC(N)=NC2=C1NC(=O)N2 CLGFIVUFZRGQRP-UHFFFAOYSA-N 0.000 description 3
- 108010061979 CEL I nuclease Proteins 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 3
- 108060004795 Methyltransferase Proteins 0.000 description 3
- 102000016397 Methyltransferase Human genes 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 102000001218 Rec A Recombinases Human genes 0.000 description 3
- 108010055016 Rec A Recombinases Proteins 0.000 description 3
- 241000204666 Thermotoga maritima Species 0.000 description 3
- 241000589500 Thermus aquaticus Species 0.000 description 3
- 229910052770 Uranium Inorganic materials 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 238000007845 assembly PCR Methods 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 238000010804 cDNA synthesis Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000037230 mobility Effects 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 150000003833 nucleoside derivatives Chemical class 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
- OHAMXGZMZZWRCA-UHFFFAOYSA-N 5-formyluracil Chemical compound OC1=NC=C(C=O)C(O)=N1 OHAMXGZMZZWRCA-UHFFFAOYSA-N 0.000 description 2
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 2
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 2
- 241000207207 Aquifex pyrophilus Species 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 241000589149 Azotobacter vinelandii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- 108010036364 Deoxyribonuclease IV (Phage T4-Induced) Proteins 0.000 description 2
- 108010069091 Dystrophin Proteins 0.000 description 2
- 108091005941 EBFP Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000606768 Haemophilus influenzae Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101150003028 Hprt1 gene Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 108010074346 Mismatch Repair Endonuclease PMS2 Proteins 0.000 description 2
- 102000008071 Mismatch Repair Endonuclease PMS2 Human genes 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000221961 Neurospora crassa Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102100037482 PMS1 protein homolog 1 Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 241000194019 Streptococcus mutans Species 0.000 description 2
- 241000589501 Thermus caldophilus Species 0.000 description 2
- 241000589499 Thermus thermophilus Species 0.000 description 2
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 2
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 2
- 241000607447 Yersinia enterocolitica Species 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 150000002009 diols Chemical group 0.000 description 2
- 150000004252 dithioacetals Chemical class 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 108010064144 endodeoxyribonuclease VII Proteins 0.000 description 2
- 108010045262 enhanced cyan fluorescent protein Proteins 0.000 description 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000009395 genetic defect Effects 0.000 description 2
- 229940047650 haemophilus influenzae Drugs 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000001638 lipofection Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000012743 protein tagging Effects 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000013120 recombinational repair Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012772 sequence design Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000005740 tumor formation Effects 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 description 2
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
- NOIRDLRUNWIUMX-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;6-amino-1h-pyrimidin-2-one Chemical compound NC=1C=CNC(=O)N=1.O=C1NC(N)=NC2=C1NC=N2 NOIRDLRUNWIUMX-UHFFFAOYSA-N 0.000 description 1
- XHBSBNYEHDQRCP-UHFFFAOYSA-N 2-amino-3-methyl-3,7-dihydro-6H-purin-6-one Chemical compound O=C1NC(=N)N(C)C2=C1N=CN2 XHBSBNYEHDQRCP-UHFFFAOYSA-N 0.000 description 1
- JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- CYSQLOSJWSVLPB-UHFFFAOYSA-N 2-methylsulfinylbutane Chemical compound CCC(C)S(C)=O CYSQLOSJWSVLPB-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- JDBGXEHEIRGOBU-UHFFFAOYSA-N 5-hydroxymethyluracil Chemical compound OCC1=CNC(=O)NC1=O JDBGXEHEIRGOBU-UHFFFAOYSA-N 0.000 description 1
- FFKUHGONCHRHPE-UHFFFAOYSA-N 5-methyl-1h-pyrimidine-2,4-dione;7h-purin-6-amine Chemical compound CC1=CNC(=O)NC1=O.NC1=NC=NC2=C1NC=N2 FFKUHGONCHRHPE-UHFFFAOYSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 241000207208 Aquifex Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000250480 Ateles belzebuth chamek Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000702199 Bacillus phage PBS2 Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 101100452003 Caenorhabditis elegans ape-1 gene Proteins 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000010804 Caulobacter vibrioides Species 0.000 description 1
- 241001467055 Caviid betaherpesvirus 2 Species 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- 108091005960 Citrine Proteins 0.000 description 1
- 102220603374 Claudin-9_V45N_mutation Human genes 0.000 description 1
- 102100022641 Coagulation factor IX Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 102000000311 Cytosine Deaminase Human genes 0.000 description 1
- 108010080611 Cytosine Deaminase Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010076804 DNA Restriction Enzymes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 108091008102 DNA aptamers Proteins 0.000 description 1
- 238000007702 DNA assembly Methods 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 102100035619 DNA-(apurinic or apyrimidinic site) lyase Human genes 0.000 description 1
- 108010060616 DNA-3-methyladenine glycosidase II Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 108010000577 DNA-Formamidopyrimidine Glycosylase Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108010082610 Deoxyribonuclease (Pyrimidine Dimer) Proteins 0.000 description 1
- 102000004099 Deoxyribonuclease (Pyrimidine Dimer) Human genes 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000006867 Discosoma Species 0.000 description 1
- 101100084900 Drosophila melanogaster Rpn11 gene Proteins 0.000 description 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
- 102000001039 Dystrophin Human genes 0.000 description 1
- 108700034637 EC 3.2.-.- Proteins 0.000 description 1
- 101710081048 Endonuclease III Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 241000701063 Gallid alphaherpesvirus 1 Species 0.000 description 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- MDCTVRUPVLZSPG-BQBZGAKWSA-N His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 MDCTVRUPVLZSPG-BQBZGAKWSA-N 0.000 description 1
- 101000968674 Homo sapiens MutS protein homolog 4 Proteins 0.000 description 1
- 101000968663 Homo sapiens MutS protein homolog 5 Proteins 0.000 description 1
- 101000738901 Homo sapiens PMS1 protein homolog 1 Proteins 0.000 description 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 241001647400 Mastigocladus laminosus Species 0.000 description 1
- 102100021157 MutS protein homolog 4 Human genes 0.000 description 1
- 102100021156 MutS protein homolog 5 Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- VEQPNABPJHWNSG-UHFFFAOYSA-N Nickel(2+) Chemical compound [Ni+2] VEQPNABPJHWNSG-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241001148157 Nostoc sp. PCC 8009 Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001603151 Philus Species 0.000 description 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
- 108010035235 Phleomycins Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 108091008103 RNA aptamers Proteins 0.000 description 1
- 239000013616 RNA primer Substances 0.000 description 1
- 241000700564 Rabbit fibroma virus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 101100425557 Rattus norvegicus Tle3 gene Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 241000242743 Renilla reniformis Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 102220467128 Runt-related transcription factor 1_L13Y_mutation Human genes 0.000 description 1
- 108700029450 S cerevisiae PMS1 Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 241000589884 Treponema pallidum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- POIOOCHMXHKUHV-UHFFFAOYSA-N [nitro-[nitro(phenyl)methoxy]methyl]benzene Chemical compound C=1C=CC=CC=1C([N+](=O)[O-])OC([N+]([O-])=O)C1=CC=CC=C1 POIOOCHMXHKUHV-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 108010039040 adenine glycosylase Proteins 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000011035 citrine Substances 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- FRTGEIHSCHXMTI-UHFFFAOYSA-N dimethyl octanediimidate Chemical compound COC(=N)CCCCCCC(=N)OC FRTGEIHSCHXMTI-UHFFFAOYSA-N 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229960004222 factor ix Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- NKKLCOFTJVNYAQ-UHFFFAOYSA-N formamidopyrimidine Chemical compound O=CNC1=CN=CN=C1 NKKLCOFTJVNYAQ-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000009429 hemophilia B Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 101150113423 hisD gene Proteins 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 108010084308 hydroxymethyluracil DNA glycosylase Proteins 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- ANCSTOBSCOWSPF-UHFFFAOYSA-N n-pyrimidin-2-ylformamide Chemical class O=CNC1=NC=CC=N1 ANCSTOBSCOWSPF-UHFFFAOYSA-N 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000005257 nucleotidylation Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical group 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108010011110 polyarginine Proteins 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 239000002342 ribonucleoside Chemical group 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- YAHHPOUXPBUKTL-DXKBKMAZSA-N thymidine dimer Chemical compound CC12C(C3N([C@H]4C[C@H](O)[C@@H](CO)O4)C(=O)NC(=O)C13C)N([C@H]1C[C@H](O)[C@@H](CO)O1)C(=O)NC2=O YAHHPOUXPBUKTL-DXKBKMAZSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 230000006648 viral gene expression Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
- 101150061422 yip5 gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61965004P | 2004-10-18 | 2004-10-18 | |
| US60/619,650 | 2004-10-18 | ||
| US64381305P | 2005-01-13 | 2005-01-13 | |
| US60/643,813 | 2005-01-13 | ||
| US65701405P | 2005-02-28 | 2005-02-28 | |
| US11/068,321 US20060194214A1 (en) | 2005-02-28 | 2005-02-28 | Methods for assembly of high fidelity synthetic polynucleotides |
| US11/067,812 | 2005-02-28 | ||
| US11/067,812 US20070122817A1 (en) | 2005-02-28 | 2005-02-28 | Methods for assembly of high fidelity synthetic polynucleotides |
| US11/068,321 | 2005-02-28 | ||
| US60/657,014 | 2005-02-28 | ||
| US69856005P | 2005-07-12 | 2005-07-12 | |
| US60/698,560 | 2005-07-12 | ||
| US72720505P | 2005-10-14 | 2005-10-14 | |
| US60/727,205 | 2005-10-14 | ||
| PCT/US2005/037571 WO2006044956A1 (en) | 2004-10-18 | 2005-10-18 | Methods for assembly of high fidelity synthetic polynucleotides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2584984A1 true CA2584984A1 (en) | 2006-04-27 |
Family
ID=35924572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002584984A Abandoned CA2584984A1 (en) | 2004-10-18 | 2005-10-18 | Methods for assembly of high fidelity synthetic polynucleotides |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070269870A1 (enExample) |
| EP (1) | EP1812598A1 (enExample) |
| JP (1) | JP2008523786A (enExample) |
| AU (1) | AU2005295351A1 (enExample) |
| CA (1) | CA2584984A1 (enExample) |
| WO (1) | WO2006044956A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114381455A (zh) * | 2014-12-16 | 2022-04-22 | 加文医学研究所 | 测序对照 |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563600B2 (en) | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
| US8338093B2 (en) | 2004-12-31 | 2012-12-25 | Affymetrix, Inc. | Primer array synthesis and validation |
| US7547775B2 (en) | 2004-12-31 | 2009-06-16 | Affymetrix, Inc. | Parallel preparation of high fidelity probes in an array format |
| US20070009928A1 (en) * | 2005-03-31 | 2007-01-11 | Lathrop Richard H | Gene synthesis using pooled DNA |
| US20060281113A1 (en) * | 2005-05-18 | 2006-12-14 | George Church | Accessible polynucleotide libraries and methods of use thereof |
| EP1987162A4 (en) * | 2006-01-23 | 2009-11-25 | Population Genetics Technologi | NUCLEIC ACID ANALYSIS ABOUT SEQUENCE TOKENS |
| WO2007123742A2 (en) * | 2006-03-31 | 2007-11-01 | Codon Devices, Inc. | Methods and compositions for increasing the fidelity of multiplex nucleic acid assembly |
| WO2007136835A2 (en) * | 2006-05-19 | 2007-11-29 | Codon Devices, Inc | Methods and cells for creating functional diversity and uses thereof |
| US20090087840A1 (en) * | 2006-05-19 | 2009-04-02 | Codon Devices, Inc. | Combined extension and ligation for nucleic acid assembly |
| WO2007136833A2 (en) * | 2006-05-19 | 2007-11-29 | Codon Devices, Inc. | Methods and compositions for aptamer production and uses thereof |
| WO2008054543A2 (en) * | 2006-05-20 | 2008-05-08 | Codon Devices, Inc. | Oligonucleotides for multiplex nucleic acid assembly |
| EP2035984A4 (en) * | 2006-06-19 | 2010-03-31 | Yeda Res & Dev | PROGRAMMABLE ITERATED ELONGATION: PROCESS FOR THE MANUFACTURE OF SYNTHETIC GENES AND COMBINATORY DNA AND PROTEIN LIBRARIES |
| US8053191B2 (en) | 2006-08-31 | 2011-11-08 | Westend Asset Clearinghouse Company, Llc | Iterative nucleic acid assembly using activation of vector-encoded traits |
| US20100323404A1 (en) * | 2007-02-09 | 2010-12-23 | Richard Lathrop | Method for recombining dna sequences and compositions related thereto |
| EP2247708A4 (en) | 2007-12-17 | 2013-02-27 | Yeda Res & Dev | SYSTEM AND METHOD FOR PROCESSING AND MANIPULATING DNA |
| US9068209B2 (en) | 2008-05-14 | 2015-06-30 | British Columbia Cancer Agency Branch | Gene synthesis by convergent assembly of oligonucleotide subsets |
| US20120171680A1 (en) * | 2008-06-12 | 2012-07-05 | Shapiro Ehud Y | Single-molecule pcr for amplification from a single nucleotide strand |
| WO2010025310A2 (en) * | 2008-08-27 | 2010-03-04 | Westend Asset Clearinghouse Company, Llc | Methods and devices for high fidelity polynucleotide synthesis |
| CN102317464B (zh) | 2008-12-12 | 2014-10-29 | 塞莱西翁有限公司 | 从α-酮酸生物合成双官能烷烃 |
| EP3257942B1 (en) | 2008-12-18 | 2020-07-22 | ITI Scotland Limited | Method for assembly of polynucleic acid sequences |
| US8404465B2 (en) | 2009-03-11 | 2013-03-26 | Celexion, Llc | Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocks |
| WO2011053957A2 (en) | 2009-11-02 | 2011-05-05 | Gen9, Inc. | Compositions and methods for the regulation of multiple genes of interest in a cell |
| WO2011056872A2 (en) * | 2009-11-03 | 2011-05-12 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| EP2504449B1 (en) * | 2009-11-25 | 2016-03-23 | Gen9, Inc. | Methods and apparatuses for chip-based dna error reduction |
| WO2011066185A1 (en) | 2009-11-25 | 2011-06-03 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| WO2011085075A2 (en) * | 2010-01-07 | 2011-07-14 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US8716467B2 (en) | 2010-03-03 | 2014-05-06 | Gen9, Inc. | Methods and devices for nucleic acid synthesis |
| WO2011143231A2 (en) * | 2010-05-10 | 2011-11-17 | The Broad Institute | High throughput paired-end sequencing of large-insert clone libraries |
| GB2481425A (en) | 2010-06-23 | 2011-12-28 | Iti Scotland Ltd | Method and device for assembling polynucleic acid sequences |
| EP2630264A4 (en) * | 2010-10-22 | 2014-04-02 | Harvard College | Orthogonal amplification and assembly of nucleic acid sequences |
| WO2012064975A1 (en) | 2010-11-12 | 2012-05-18 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| CA2817697C (en) * | 2010-11-12 | 2021-11-16 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
| WO2012103442A2 (en) | 2011-01-28 | 2012-08-02 | The Broad Institute, Inc. | Paired end bead amplification and high throughput sequencing |
| US9567649B2 (en) | 2011-04-28 | 2017-02-14 | Jørn Erland Koch | System for identification of microorganism and detection of infectious disease |
| US9752176B2 (en) | 2011-06-15 | 2017-09-05 | Ginkgo Bioworks, Inc. | Methods for preparative in vitro cloning |
| AU2012272644B2 (en) | 2011-06-23 | 2017-03-23 | Rho Renewables, Inc. | Recombinant production systems for aromatic molecules |
| US9340826B2 (en) * | 2011-08-01 | 2016-05-17 | Celemics, Inc. | Method of preparing nucleic acid molecules |
| US10364464B2 (en) | 2011-08-08 | 2019-07-30 | The Broad Institute, Inc. | Compositions and methods for co-amplifying subsequences of a nucleic acid fragment sequence |
| JP2014526899A (ja) * | 2011-08-26 | 2014-10-09 | ジェン９・インコーポレイテッド | 核酸の高忠実度アセンブリのための組成物および方法 |
| CA2862149C (en) | 2012-02-01 | 2022-07-26 | Synthetic Genomics, Inc. | Materials and methods for the synthesis of error-minimized nucleic acid molecules |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| CA2871505C (en) | 2012-04-24 | 2021-10-12 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| WO2014004393A1 (en) | 2012-06-25 | 2014-01-03 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| JP6510407B2 (ja) * | 2012-08-16 | 2019-05-08 | シンセティック ジェノミクス インコーポレーテッド | デジタル生物学的コンバータ |
| WO2014028026A1 (en) | 2012-08-17 | 2014-02-20 | Celexion, Llc | Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocks |
| US9809833B2 (en) | 2012-09-20 | 2017-11-07 | Bioamber Inc. | Pathways to adipate semialdehyde and other organic products |
| CA2885058A1 (en) * | 2012-10-08 | 2014-04-17 | Spiral Genetics Inc. | Methods and systems for identifying, from read symbol sequences, variations with respect to a reference symbol sequence |
| CA2897390A1 (en) | 2013-01-10 | 2014-07-17 | Ge Healthcare Dharmacon, Inc. | Templates, libraries, kits and methods for generating molecules |
| WO2014160059A1 (en) * | 2013-03-13 | 2014-10-02 | Gen9, Inc. | Compositions and methods for synthesis of high fidelity oligonucleotides |
| US9567632B2 (en) * | 2013-03-19 | 2017-02-14 | New England Biolabs, Inc. | Enrichment of target sequences |
| CN104178477A (zh) * | 2013-05-28 | 2014-12-03 | 中国人民解放军军事医学科学院生物工程研究所 | 一种基因合成的方法 |
| KR102160389B1 (ko) | 2013-08-05 | 2020-09-28 | 트위스트 바이오사이언스 코포레이션 | 드 노보 합성된 유전자 라이브러리 |
| CN105917002A (zh) * | 2013-11-18 | 2016-08-31 | 鲁比康基因组学公司 | 用于减少背景的可降解适体 |
| US9834814B2 (en) * | 2013-11-22 | 2017-12-05 | Agilent Technologies, Inc. | Spatial molecular barcoding of in situ nucleic acids |
| JOP20200257A1 (ar) * | 2014-05-01 | 2017-06-16 | Geron Corp | تركيبات أوليجو نوكليوتيد وطرق لتحضيرها |
| WO2015184016A2 (en) * | 2014-05-27 | 2015-12-03 | The Broad Institute, Inc. | High-thoughput assembly of genetic elements |
| US10040048B1 (en) | 2014-09-25 | 2018-08-07 | Synthego Corporation | Automated modular system and method for production of biopolymers |
| WO2016064856A1 (en) * | 2014-10-21 | 2016-04-28 | Gen9, Inc. | Methods for nucleic acid assembly |
| CA2975855C (en) | 2015-02-04 | 2025-09-23 | Twist Bioscience Corporation | SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS |
| CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| WO2016210191A1 (en) * | 2015-06-23 | 2016-12-29 | Tupac Bio, Inc. | Computer-implemented method for designing synthetic dna, and terminal, system and computer-readable medium for the same |
| KR20180050411A (ko) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | 올리고핵산 변이체 라이브러리 및 그의 합성 |
| WO2017053450A1 (en) | 2015-09-22 | 2017-03-30 | Twist Bioscience Corporation | Flexible substrates for nucleic acid synthesis |
| EP3384077A4 (en) | 2015-12-01 | 2019-05-08 | Twist Bioscience Corporation | FUNCTIONALIZED SURFACES AND MANUFACTURE THEREOF |
| CA3032287A1 (en) * | 2016-07-28 | 2018-02-01 | Ginkgo Bioworks, Inc. | Device and method for nucleic acid manipulation |
| WO2018038772A1 (en) | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
| EP4664304A3 (en) | 2016-09-21 | 2026-01-21 | Atlas Data Storage, Inc. | Nucleic acid based data storage |
| WO2018111914A1 (en) * | 2016-12-14 | 2018-06-21 | Synthetic Genomics, Inc. | Methods for assembling dna molecules |
| GB2573069A (en) | 2016-12-16 | 2019-10-23 | Twist Bioscience Corp | Variant libraries of the immunological synapse and synthesis thereof |
| WO2018156792A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
| CA3056388A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| WO2018203056A1 (en) * | 2017-05-03 | 2018-11-08 | Oxford University Innovation Ltd. | Dna assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for assembling continuous nucleic acids |
| CN111566125A (zh) | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | Gpcr结合蛋白及其合成 |
| EP3681637A4 (en) * | 2017-09-11 | 2021-06-02 | Synthego Corporation | SYSTEM AND PROCEDURE FOR BIOPOLYMER SYNTHESIS |
| GB2566986A (en) | 2017-09-29 | 2019-04-03 | Evonetix Ltd | Error detection during hybridisation of target double-stranded nucleic acid |
| CN111565834B (zh) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | 用于多核苷酸合成的加热的纳米孔 |
| US11732257B2 (en) | 2017-10-23 | 2023-08-22 | Massachusetts Institute Of Technology | Single cell sequencing libraries of genomic transcript regions of interest in proximity to barcodes, and genotyping of said libraries |
| US20200299684A1 (en) * | 2017-10-27 | 2020-09-24 | Twist Bioscience Corporation | Systems and methods for polynucleotide scoring |
| IL312616B2 (en) | 2018-01-04 | 2025-08-01 | Twist Bioscience Corp | Dna-based digital information storage |
| US12595476B2 (en) | 2018-03-19 | 2026-04-07 | Modernatx, Inc. | Assembly and error reduction of synthetic genes from oligonucleotides |
| EP3814497A4 (en) | 2018-05-18 | 2022-03-02 | Twist Bioscience Corporation | POLYNUCLEOTIDES, REAGENTS AND METHODS FOR NUCLEIC ACID HYBRIDIZATION |
| CN109628556A (zh) * | 2018-11-27 | 2019-04-16 | 山东师范大学 | 基于自催化复制介导的循环信号放大检测人8-羟基鸟嘌呤dna糖基化酶活性的方法 |
| EP3902816A4 (en) | 2018-12-26 | 2022-09-14 | Twist Bioscience Corporation | HIGH-PRECISION DE NOVO POLYNUCLEOTIDE SYNTHESIS |
| WO2020146425A1 (en) | 2019-01-07 | 2020-07-16 | Elegen Corporation | Methods of using microfluidic positional encoding devices |
| WO2020176548A1 (en) * | 2019-02-25 | 2020-09-03 | Matthew Hill | Methods of using microfluidic positional encoding devices |
| CA3131689A1 (en) | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for glp1 receptor |
| KR20210144698A (ko) | 2019-02-26 | 2021-11-30 | 트위스트 바이오사이언스 코포레이션 | 항체 최적화를 위한 변이 핵산 라이브러리 |
| GB201905303D0 (en) * | 2019-04-15 | 2019-05-29 | Thermo Fisher Scient Geneart Gmbh | Multiplex assembly of nucleic acid molecules |
| EP3987019A4 (en) | 2019-06-21 | 2023-04-19 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
| CN115023440B (zh) | 2019-09-23 | 2025-09-12 | 特韦斯特生物科学公司 | 结合CD3ε的抗体 |
| WO2021110992A1 (en) | 2019-12-04 | 2021-06-10 | Synbionik Gmbh | Non-naturally occurring bacteria modified able to produce tryptophan derived compounds |
| WO2021110993A1 (en) | 2019-12-04 | 2021-06-10 | Synbionik Gmbh | An efficient shuttle vector system for the expression of heterologous and homologous proteins for the genus zymomonas |
| AU2020400030B2 (en) | 2019-12-09 | 2026-05-21 | Twist Bioscience Corporation | Variant nucleic acid libraries for adenosine receptors |
| EP3957726A1 (en) | 2020-08-21 | 2022-02-23 | Synbionik GmbH | Biosynthesis and method of production of psilocin and psilocybin in microorganisms |
| EP4208565A4 (en) * | 2020-09-01 | 2024-10-09 | Replay Holdings, LLC | Methods and systems for nucleic acid synthesis |
| US12624392B2 (en) | 2020-12-30 | 2026-05-12 | 10X Genomics, Inc. | Molecular array generation using photoresist |
| US20250034550A1 (en) * | 2021-11-24 | 2025-01-30 | Guangzhou Chengyuan Bioimmunology Technology Co., Ltd. | Compositions and methods for polynucleotide assembly |
| GB2619548B (en) * | 2022-06-10 | 2024-11-20 | Nunabio Ltd | Nucleic acid and gene synthesis |
| GB2631890B (en) * | 2022-06-10 | 2025-09-03 | Nunabio Ltd | Nucleic acid and gene synthesis |
| ES3005088T3 (en) * | 2022-06-29 | 2025-03-13 | 10X Genomics Inc | High definition molecular array feature generation using photoresist |
| US20240117338A1 (en) * | 2022-06-29 | 2024-04-11 | 10X Genomics, Inc. | Methods and compositions for refining feature boundaries in molecular arrays |
| WO2024132094A1 (en) | 2022-12-19 | 2024-06-27 | Thermo Fisher Scientific Geneart Gmbh | Retrieval of sequence-verified nucleic acid molecules |
| EP4784779A1 (en) * | 2023-09-26 | 2026-08-05 | Instance, Inc. | Ultra-high capacity dna synthesis to power functionally generative biological design |
Family Cites Families (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096825A (en) * | 1983-01-12 | 1992-03-17 | Chiron Corporation | Gene for human epidermal growth factor and synthesis and expression thereof |
| US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5093251A (en) * | 1986-05-23 | 1992-03-03 | California Institute Of Technology | Cassette method of gene synthesis |
| US5525464A (en) * | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
| AU3869289A (en) * | 1988-07-14 | 1990-02-05 | Baylor College Of Medicine | Solid phase assembly and reconstruction of biopolymers |
| US5132215A (en) * | 1988-09-15 | 1992-07-21 | Eastman Kodak Company | Method of making double-stranded dna sequences |
| US5082767A (en) * | 1989-02-27 | 1992-01-21 | Hatfield G Wesley | Codon pair utilization |
| US5556750A (en) * | 1989-05-12 | 1996-09-17 | Duke University | Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
| EP1382386A3 (en) * | 1992-02-19 | 2004-12-01 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
| US5436150A (en) * | 1992-04-03 | 1995-07-25 | The Johns Hopkins University | Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease |
| US5750335A (en) * | 1992-04-24 | 1998-05-12 | Massachusetts Institute Of Technology | Screening for genetic variation |
| US6027877A (en) * | 1993-11-04 | 2000-02-22 | Gene Check, Inc. | Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification |
| US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6335160B1 (en) * | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5928905A (en) * | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5837458A (en) * | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5834252A (en) * | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| ATE236270T1 (de) * | 1995-12-15 | 2003-04-15 | Univ Duke | Verfahren zum nachweis und zur entfernung von mutantsequenzen, die während enzymatischer amplifikation entstehen |
| US6261797B1 (en) * | 1996-01-29 | 2001-07-17 | Stratagene | Primer-mediated polynucleotide synthesis and manipulation techniques |
| US6013440A (en) * | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
| US5851804A (en) * | 1996-05-06 | 1998-12-22 | Apollon, Inc. | Chimeric kanamycin resistance gene |
| SE9602062D0 (sv) * | 1996-05-29 | 1996-05-29 | Pharmacia Biotech Ab | Method for detection of mutations |
| EP0915903A4 (en) * | 1996-06-17 | 2002-09-04 | Biodynamics Associates | PROCESS AND KITS FOR PREPARING CONSTRUCTIONS OF MULTI-CONSTITUENT NUCLEIC ACIDS |
| US6495318B2 (en) * | 1996-06-17 | 2002-12-17 | Vectorobjects, Llc | Method and kits for preparing multicomponent nucleic acid constructs |
| US6114148C1 (en) * | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| IL120339A0 (en) * | 1997-02-27 | 1997-06-10 | Gesher Israel Advanced Biotecs | Improved DNA assembly method |
| US6221586B1 (en) * | 1997-04-09 | 2001-04-24 | California Institute Of Technology | Electrochemical sensor using intercalative, redox-active moieties |
| US6410225B1 (en) * | 1997-06-27 | 2002-06-25 | Yale University | Purification of oligomers |
| US6489141B1 (en) * | 1997-07-09 | 2002-12-03 | The University Of Queensland | Nucleic acid sequence and methods for selectively expressing a protein in a target cell or tissue |
| US6326489B1 (en) * | 1997-08-05 | 2001-12-04 | Howard Hughes Medical Institute | Surface-bound, bimolecular, double-stranded DNA arrays |
| DE19736591A1 (de) * | 1997-08-22 | 1999-02-25 | Peter Prof Dr Hegemann | Verfahren zum Herstellen von Nukleinsäurepolymeren |
| WO1999010369A1 (en) * | 1997-08-28 | 1999-03-04 | Thomas Jefferson University | Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins |
| US6136568A (en) * | 1997-09-15 | 2000-10-24 | Hiatt; Andrew C. | De novo polynucleotide synthesis using rolling templates |
| US6670127B2 (en) * | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
| ES2243007T3 (es) * | 1997-09-16 | 2005-11-16 | Egea Biosciences Llc | Sintesis quimica completa y sintesis de genes de genomas. |
| US20020127552A1 (en) * | 1997-10-10 | 2002-09-12 | Church George M | Replica amplification of nucleic acid arrays |
| EP1021558A1 (en) * | 1997-10-10 | 2000-07-26 | President And Fellows Of Harvard College | Surface-bound, double-stranded dna protein arrays |
| ES2337027T3 (es) * | 1997-12-05 | 2010-04-20 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Nuevo metodo de clonacion de dna basado en el sistema de recombinacion rece-rect de e. coli. |
| US6150102A (en) * | 1998-02-03 | 2000-11-21 | Lucent Technologies Inc. | Method of generating nucleic acid oligomers of known composition |
| US6287825B1 (en) * | 1998-09-18 | 2001-09-11 | Molecular Staging Inc. | Methods for reducing the complexity of DNA sequences |
| US5942609A (en) * | 1998-11-12 | 1999-08-24 | The Porkin-Elmer Corporation | Ligation assembly and detection of polynucleotides on solid-support |
| US6358712B1 (en) * | 1999-01-05 | 2002-03-19 | Trustee Of Boston University | Ordered gene assembly |
| US20040005673A1 (en) * | 2001-06-29 | 2004-01-08 | Kevin Jarrell | System for manipulating nucleic acids |
| US20030054390A1 (en) * | 1999-01-19 | 2003-03-20 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| ATE334197T1 (de) * | 1999-02-19 | 2006-08-15 | Febit Biotech Gmbh | Verfahren zur herstellung von polymeren |
| WO2000053617A1 (en) * | 1999-03-08 | 2000-09-14 | Protogene Laboratories, Inc. | Methods and compositions for economically synthesizing and assembling long dna sequences |
| AU2001227679A1 (en) * | 2000-02-25 | 2001-09-03 | General Atomics | Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods |
| US20010044111A1 (en) * | 2000-03-20 | 2001-11-22 | Brian Carr | Method for generating recombinant DNA molecules in complex mixtures |
| US6365355B1 (en) * | 2000-03-28 | 2002-04-02 | The Regents Of The University Of California | Chimeric proteins for detection and quantitation of DNA mutations, DNA sequence variations, DNA damage and DNA mismatches |
| US6969587B2 (en) * | 2000-04-04 | 2005-11-29 | Taylor Paul D | Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| AU2001264802A1 (en) * | 2000-05-21 | 2001-12-03 | University Of North Carolina At Chapel Hill | Assembly of large viral genomes and chromosomes from subclones |
| US7244560B2 (en) * | 2000-05-21 | 2007-07-17 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| US6664112B2 (en) * | 2000-06-02 | 2003-12-16 | Blue Heron Biotechnology, Inc. | Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides |
| CN1232343C (zh) * | 2000-07-03 | 2005-12-21 | 艾克索特罗恩公司 | 利用光生反应物进行化学反应的设备及方法 |
| US20030017552A1 (en) * | 2000-07-21 | 2003-01-23 | Jarrell Kevin A. | Modular vector systems |
| US20020133359A1 (en) * | 2000-12-26 | 2002-09-19 | Appareon | System, method and article of manufacture for country and regional treatment in a supply chain system |
| US7211654B2 (en) * | 2001-03-14 | 2007-05-01 | Regents Of The University Of Michigan | Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| US20020165175A1 (en) * | 2001-04-17 | 2002-11-07 | Xiaowu Liang | Fast and enzymeless cloning of nucleic acid fragments |
| ES2464532T3 (es) * | 2001-04-19 | 2014-06-03 | The Scripps Research Institute | Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa |
| IL158487A0 (en) * | 2001-05-18 | 2004-05-12 | Wisconsin Alumni Res Found | Method for the synthesis of dna sequences |
| WO2002099080A2 (en) * | 2001-06-05 | 2002-12-12 | Gorilla Genomics, Inc. | Methods for low background cloning of dna using long oligonucleotides |
| WO2003014325A2 (en) * | 2001-08-10 | 2003-02-20 | Xencor | Protein design automation for protein libraries |
| WO2003033718A1 (en) * | 2001-10-17 | 2003-04-24 | Global Genomics Ab | Synthesis of oligonucleotides on solid support and assembly into doublestranded polynucleotides |
| AU2002365811A1 (en) * | 2001-12-03 | 2003-06-17 | Zymogenetics, Inc. | Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations |
| WO2003057924A1 (en) * | 2002-01-04 | 2003-07-17 | Board Of Regents, The University Of Texas System | Proofreading, error deletion, and ligation method for synthesis of high-fidelity polynucleotide sequences |
| US20030215837A1 (en) * | 2002-01-14 | 2003-11-20 | Diversa Corporation | Methods for purifying double-stranded nucleic acids lacking base pair mismatches or nucleotide gaps |
| US6673552B2 (en) * | 2002-01-14 | 2004-01-06 | Diversa Corporation | Methods for purifying annealed double-stranded oligonucleotides lacking base pair mismatches or nucleotide gaps |
| JP2005514927A (ja) * | 2002-01-14 | 2005-05-26 | ディヴァーサ コーポレイション | ポリヌクレオチドの製造方法及び二本鎖ポリヌクレオチドの精製方法 |
| US7422851B2 (en) * | 2002-01-31 | 2008-09-09 | Nimblegen Systems, Inc. | Correction for illumination non-uniformity during the synthesis of arrays of oligomers |
| US7399590B2 (en) * | 2002-02-21 | 2008-07-15 | Asm Scientific, Inc. | Recombinase polymerase amplification |
| JP4455061B2 (ja) * | 2002-02-28 | 2010-04-21 | ウイスコンシン アラムニ リサーチ ファンデーション | 核酸集団のエラー減少方法 |
| US7135286B2 (en) * | 2002-03-26 | 2006-11-14 | Perlegen Sciences, Inc. | Pharmaceutical and diagnostic business systems and methods |
| US7482119B2 (en) * | 2002-04-01 | 2009-01-27 | Blue Heron Biotechnology, Inc. | Solid phase methods for polynucleotide production |
| US7273730B2 (en) * | 2002-05-24 | 2007-09-25 | Invitrogen Corporation | Nested PCR employing degradable primers |
| US7563600B2 (en) * | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
| WO2004024915A1 (en) * | 2002-09-13 | 2004-03-25 | The University Of Queensland | Gene expression system based on codon translation efficiency |
| US20040166567A1 (en) * | 2002-09-26 | 2004-08-26 | Santi Daniel V | Synthetic genes |
| WO2004031351A2 (en) * | 2002-10-01 | 2004-04-15 | Nimblegen Systems, Inc. | Microarrays having multiple oligonucleotides in single array features |
| US6790305B2 (en) * | 2002-10-08 | 2004-09-14 | International Business Machines Corporation | Method and structure for small pitch z-axis electrical interconnections |
| US7879580B2 (en) * | 2002-12-10 | 2011-02-01 | Massachusetts Institute Of Technology | Methods for high fidelity production of long nucleic acid molecules |
| US7932025B2 (en) * | 2002-12-10 | 2011-04-26 | Massachusetts Institute Of Technology | Methods for high fidelity production of long nucleic acid molecules with error control |
| US7521242B2 (en) * | 2003-05-09 | 2009-04-21 | The United States Of America As Represented By The Department Of Health And Human Services | Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids |
| EP1629097A1 (en) * | 2003-05-22 | 2006-03-01 | University of California | Method for producing a synthetic gene or other dna sequence |
| US8133670B2 (en) * | 2003-06-13 | 2012-03-13 | Cold Spring Harbor Laboratory | Method for making populations of defined nucleic acid molecules |
| US20050069928A1 (en) * | 2003-08-04 | 2005-03-31 | Blue Heron Biotechnology, Inc. | Methods for synthesis of defined polynucleotides |
| EP1733055A4 (en) * | 2004-02-27 | 2009-03-11 | Harvard College | polynucleotide |
| US7432055B2 (en) * | 2004-03-05 | 2008-10-07 | Uchicago Argonne Llc | Dual phase multiplex polymerase chain reaction |
| US20050240352A1 (en) * | 2004-04-23 | 2005-10-27 | Invitrogen Corporation | Online procurement of biologically related products/services using interactive context searching of biological information |
-
2005
- 2005-10-18 AU AU2005295351A patent/AU2005295351A1/en not_active Abandoned
- 2005-10-18 US US11/254,250 patent/US20070269870A1/en not_active Abandoned
- 2005-10-18 WO PCT/US2005/037571 patent/WO2006044956A1/en not_active Ceased
- 2005-10-18 CA CA002584984A patent/CA2584984A1/en not_active Abandoned
- 2005-10-18 JP JP2007537994A patent/JP2008523786A/ja active Pending
- 2005-10-18 EP EP05815025A patent/EP1812598A1/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114381455A (zh) * | 2014-12-16 | 2022-04-22 | 加文医学研究所 | 测序对照 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070269870A1 (en) | 2007-11-22 |
| WO2006044956A1 (en) | 2006-04-27 |
| EP1812598A1 (en) | 2007-08-01 |
| JP2008523786A (ja) | 2008-07-10 |
| AU2005295351A1 (en) | 2006-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070269870A1 (en) | Methods for assembly of high fidelity synthetic polynucleotides | |
| US20070122817A1 (en) | Methods for assembly of high fidelity synthetic polynucleotides | |
| US20060194214A1 (en) | Methods for assembly of high fidelity synthetic polynucleotides | |
| US10190164B2 (en) | Method of making a paired tag library for nucleic acid sequencing | |
| JP7460539B2 (ja) | 核酸を結合、修飾、および切断する物質の基質選択性および部位のためのｉｎ ｖｉｔｒｏでの高感度アッセイ | |
| US20060127920A1 (en) | Polynucleotide synthesis | |
| CN104685116A (zh) | 用于核酸组装和高通量测序的方法 | |
| WO2008054543A2 (en) | Oligonucleotides for multiplex nucleic acid assembly | |
| CN102203273A (zh) | 生成基因特异性的文库的方法 | |
| EP1781786A2 (en) | Method of error reduction in nucleic acid populations | |
| CN113166798A (zh) | 通过核酸内切酶保护的靶向富集 | |
| US20200102612A1 (en) | Method for identifying the source of an amplicon | |
| AU2003267008B2 (en) | Method for the selective combinatorial randomization of polynucleotides | |
| WO2001029212A1 (en) | Methods for chimeragenesis of whole genomes or large polynucleotides | |
| WO2024209000A1 (en) | Linkers for duplex sequencing | |
| EP4267763B1 (en) | Compositions and methods for highly sensitive detection of target sequences in multiplex reactions | |
| CA2962254C (en) | Composition and method for processing dna | |
| US20080213841A1 (en) | Novel Method for Assembling DNA Metasegments to use as Substrates for Homologous Recombination in a Cell | |
| CN117015602A (zh) | 分析细胞中蛋白质编码变体的表达 | |
| US20040132054A1 (en) | Method for the selective combinatorial randomization of polynucleotides | |
| JP2003038177A (ja) | 標的塩基配列が改変されたｄｎａライブラリーの作製方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |